97 related articles for article (PubMed ID: 29054485)
1. Genetic correlates of insight in schizophrenia.
Xavier RM; Vorderstrasse A; Keefe RSE; Dungan JR
Schizophr Res; 2018 May; 195():290-297. PubMed ID: 29054485
[TBL] [Abstract][Full Text] [Related]
2. Polygenic signal for symptom dimensions and cognitive performance in patients with chronic schizophrenia.
Xavier RM; Dungan JR; Keefe RSE; Vorderstrasse A
Schizophr Res Cogn; 2018 Jun; 12():11-19. PubMed ID: 29552508
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
[TBL] [Abstract][Full Text] [Related]
4. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
[TBL] [Abstract][Full Text] [Related]
5. Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort.
Santoro ML; Ota V; de Jong S; Noto C; Spindola LM; Talarico F; Gouvea E; Lee SH; Moretti P; Curtis C; Patel H; Newhouse S; Carvalho CM; Gadelha A; Cordeiro Q; Bressan RA; Belangero SI; Breen G
Transl Psychiatry; 2018 Aug; 8(1):174. PubMed ID: 30171181
[TBL] [Abstract][Full Text] [Related]
6. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; ; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard JR; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
JAMA Psychiatry; 2022 Mar; 79(3):260-269. PubMed ID: 35019943
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium.
Peterson RE; Bigdeli TB; Ripke S; Bacanu SA; Gejman PV; Levinson DF; Li QS; Rujescu D; Rietschel M; Weinberger DR; Straub RE; Walters JTR; Owen MJ; O'Donovan MC; Mowry BJ; Ophoff RA; Andreassen OA; Esko T; Petryshen TL; Kendler KS; ; Fanous AH
J Psychiatr Res; 2021 May; 137():215-224. PubMed ID: 33691233
[TBL] [Abstract][Full Text] [Related]
8. Polygenic associations of neurodevelopmental genes in suicide attempt.
Sokolowski M; Wasserman J; Wasserman D
Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
Okhuijsen-Pfeifer C; van der Horst MZ; Bousman CA; Lin B; van Eijk KR; Ripke S; Ayhan Y; Babaoglu MO; Bak M; Alink W; van Beek H; Beld E; Bouhuis A; Edlinger M; Erdogan IM; Ertuğrul A; Yoca G; Everall IP; Görlitz T; ; Grootens KP; Gutwinski S; Hallikainen T; Jeger-Land E; de Koning M; Lähteenvuo M; Legge SE; Leucht S; Morgenroth C; Müderrisoğlu A; Narang A; Pantelis C; Pardiñas AF; Oviedo-Salcedo T; Schneider-Thoma J; Schreiter S; Repo-Tiihonen E; Tuppurainen H; Veereschild M; Veerman S; de Vos M; Wagner E; Cohen D; Bogers JPAM; Walters JTR; Yağcıoğlu AEA; Tiihonen J; Hasan A; Luykx JJ
Transl Psychiatry; 2022 Apr; 12(1):145. PubMed ID: 35393395
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia.
Wang SH; Hsiao PC; Yeh LL; Liu CM; Liu CC; Hwang TJ; Hsieh MH; Chien YL; Lin YT; Chandler SD; Faraone SV; Laird N; Neale B; McCarroll SA; Glatt SJ; Tsuang MT; Hwu HG; Chen WJ
Genes Brain Behav; 2018 Jan; 17(1):49-55. PubMed ID: 28719030
[TBL] [Abstract][Full Text] [Related]
11. Identification of relevant hub genes for early intervention at gene coexpression modules with altered predicted expression in schizophrenia.
Rodriguez-López J; Arrojo M; Paz E; Páramo M; Costas J
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109815. PubMed ID: 31715283
[TBL] [Abstract][Full Text] [Related]
12. Testing for polygenic effects in genome-wide association studies.
Pan W; Chen YM; Wei P
Genet Epidemiol; 2015 May; 39(4):306-16. PubMed ID: 25847094
[TBL] [Abstract][Full Text] [Related]
13. Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.
Li J; Yoshikawa A; Brennan MD; Ramsey TL; Meltzer HY
Schizophr Res; 2018 Feb; 192():194-204. PubMed ID: 28431800
[TBL] [Abstract][Full Text] [Related]
14. Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
Facal F; Arrojo M; Paz E; Páramo M; Costas J
Acta Psychiatr Scand; 2022 Aug; 146(2):139-150. PubMed ID: 35582973
[TBL] [Abstract][Full Text] [Related]
15. Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
Hettige NC; Cole CB; Khalid S; De Luca V
Schizophr Res; 2016 Feb; 170(2-3):265-70. PubMed ID: 26778674
[TBL] [Abstract][Full Text] [Related]
16. Polygenic risk scores in schizophrenia with clinically significant copy number variants.
Taniguchi S; Ninomiya K; Kushima I; Saito T; Shimasaki A; Sakusabe T; Momozawa Y; Kubo M; Kamatani Y; Ozaki N; Ikeda M; Iwata N
Psychiatry Clin Neurosci; 2020 Jan; 74(1):35-39. PubMed ID: 31461559
[TBL] [Abstract][Full Text] [Related]
17. Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia.
Curtis D
Psychiatr Genet; 2018 Oct; 28(5):85-89. PubMed ID: 30160659
[TBL] [Abstract][Full Text] [Related]
18. Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.
Crisafulli C; Chiesa A; De Ronchi D; Han C; Lee SJ; Park MH; Patkar AA; Pae CU; Serretti A
Neurosci Lett; 2012 Jan; 506(1):170-4. PubMed ID: 22094384
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
Le Hellard S; Mühleisen TW; Djurovic S; Fernø J; Ouriaghi Z; Mattheisen M; Vasilescu C; Raeder MB; Hansen T; Strohmaier J; Georgi A; Brockschmidt FF; Melle I; Nenadic I; Sauer H; Rietschel M; Nöthen MM; Werge T; Andreassen OA; Cichon S; Steen VM
Mol Psychiatry; 2010 May; 15(5):463-72. PubMed ID: 18936756
[TBL] [Abstract][Full Text] [Related]
20. Polygenic risk for schizophrenia and associated brain structural changes: A systematic review.
van der Merwe C; Passchier R; Mufford M; Ramesar R; Dalvie S; Stein DJ
Compr Psychiatry; 2019 Jan; 88():77-82. PubMed ID: 30529765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
